Open label randomized controlled trial of the efficacy and safety of NexoBrid compared to standard of care in children with burns
BBD was demonstrated to be safe and effective in children. Its use lead to a shorter time to complete eschar removal, a reduction in excisional surgery and non-inferior cosmesis and function results as compared to SOC eschar removal methods.
Authors
- Adam J. Singer (ORCID: https://orcid.org/0000-0003-4694-6152)
- Raphael Staubach (ORCID: https://orcid.org/0000-0002-3293-2879)
- Yaron Shoham (ORCID: https://orcid.org/0000-0002-6222-5657)
- Manoj K. Jha (ORCID: https://orcid.org/0000-0001-7351-4764)
- Giavonni Lewis (ORCID: https://orcid.org/0000-0001-6324-684X)
- Stan Monstrey (ORCID: https://orcid.org/0000-0002-2270-0732)
- Shawn D. Larson (ORCID: https://orcid.org/0000-0002-8564-0140)
- Lior Rosenberg
- Ram Narayan
- Yvonne Wilson
- Ruzsena Bene
- Mohan Kakola
Institutions
- Ben-Gurion University of the Negev (IL)
- Safdarjang Hospital (IN)
- UF Health Shands Hospital (US)
- University of Mysore (IN)
- Soroka Medical Center (IL)
- Ghent University Hospital (BE)
- Bethesda Hospital (IN)
- University of Utah Hospital (US)
- Stony Brook School (US)
- Birmingham Children's Hospital (GB)
- Olgahospital (DE)
- MediWound (Israel) (IL)
- Klinikum Stuttgart (DE)
- Stony Brook University (US)
Publication Details
- Journal
- Burns
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.burns.2025.107417
- Citations
- 4
- Primary Topic
- Burn Injury Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Biomedical Advanced Research and Development Authority